Results showed that 6 (CDKN1A, ABL1, BTN2A1, ENPP1, CNST and SYNM) and 2 (CLOCK and SUZ12) sub-ceRNA networks for CML and AML respectively [12]. This evidence concerns the gene BTN2A1 and chronic myelogenous leukemia, BCR-ABL1 positive.